As early and effective antiretroviral therapy has become more widespread, HIV has
transitioned from a progressive, fatal disease to a chronic, manageable disease marked by …

Although INSTI-based regimens are highly efficacious for viral suppression, they appear to
cause more weight gain and treatment emergent obesity than non-INSTI-based regimens …

Early in the HIV epidemic, lipodystrophy, characterized by subcutaneous fat loss
(lipoatrophy), with or without central fat accumulation (lipohypertrophy), was recognized as a …

Since the introduction of combined antiretroviral therapy (cART) and more effective
treatments for AIDS, there has been a dramatic shift from the weight loss and wasting that …

Aims With the success of antiretroviral therapy (ART), non-human immunodeficiency virus
(HIV)-related comorbidities like cardiovascular diseases (CVDs) are of increasing concern …

Background Aim of this review is to focus the attention on people living with HIV infection at
risk of developing a cardiovascular event. What is or what would be the most suitable …

It has long been known that aging, at both the cellular and organismal levels, contributes to
the development and progression of the pathology of many chronic diseases. However …

Abstract Purpose of Review The aim of this review is to summarize knowledge of the
prevalence, relevant physiology, and consequences of obesity and visceral adiposity in HIV …

Background. Impaired cardiac function persists in the era of effective human
immunodeficiency virus (HIV) therapy, although the etiology is unclear. We used magnetic …

As antiretroviral therapy has decreased human immunodeficiency virus (HIV)–associated
mortality, cardiometabolic abnormalities have become increasingly apparent in HIV-infected …